Advertisement

University of Maryland’s Owonikoko: What it means to be a Black director of an NCI-designated cancer center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A month after reporting to work in the top job at the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Taofeek K. Owonikoko reflected on the obligations that come with being a Black director of an NCI-designated cancer center:

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Advertisement
Advertisement
Amy Lacey
VCU Massey Comprehensive Cancer Center
Otis W. Brawley, MD, MACP
Bloomberg Distinguished Professor of Oncology and Epidemiology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; Former chief medical and scientific officer, American Cancer Society
Paul Goldberg
Editor & Publisher
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

Technological innovations are often hailed as transformative tools capable of revolutionizing healthcare. From gene editing for conditions like sickle cell disease to AI predicting hospital readmissions, to telemedicine expanding healthcare access, these advancements have the potential to change the way we treat diseases. 
Advertisement
Advertisement